4CPS-064 Quality of life study: galcanezumab in the treatment of migraine

Autor: EM Barreiro Fernandez, E Rios-Sanchez, CM Dominguez-Santana, C Moreno-Ramos, MD Gil-Sierra
Rok vydání: 2022
Zdroj: Section 4: Clinical pharmacy services.
DOI: 10.1136/ejhpharm-2022-eahp.103
Databáze: OpenAIRE